Childhood teratoma of the ovary

Summary

Childhood teratoma of the ovary (MONDO:0003819) is a disease. A subtype of pediatric ovarian germ cell tumor — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	childhood teratoma of the ovary
Mondo ID	MONDO:0003819
DOID	DOID:6230
NCIT	C6554
UMLS	C1332992
MedGen	272466
GARD	0023682
Is cancer (heuristic)	no

Also known as: childhood ovarian teratoma · childhood teratoma of ovary · childhood teratoma of the ovary · ovarian teratoma of childhood · paediatric ovarian teratoma · paediatric teratoma of ovary · paediatric teratoma of the ovary · pediatric ovarian teratoma · pediatric teratoma of ovary · pediatric teratoma of the ovary

Disease family

This is a subtype of pediatric ovarian germ cell tumor. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › germ cell tumor › childhood germ cell tumor › pediatric ovarian germ cell tumor › childhood teratoma of the ovary

Related subtypes (4): childhood ovarian yolk sac tumor, pediatric ovarian dysgerminoma, childhood ovarian embryonal carcinoma, childhood choriocarcinoma of the ovary

Subtypes (2): childhood mature teratoma of the ovary, childhood immature teratoma of ovary

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.